Avedro Inc (AVDR) Inventory Turnover Ratio, from third quarter 2019 to third quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Avedro Inc  (NASDAQ: AVDR)
 

Avedro Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Avedro Inc's inventory turnover ratio, the ratio that measures Avedro Inc's ability to manage its supply chain, sequentially decreased to 2.28 in the third quarter 2019, but it does not raise any concerns as Avedro Inc continue to execute well, and the inventory turnover ratio remains above the average. Avedro Inc's average inventory processing period in the Sep 30 2019 quarter, has increased to 160 days, from 117 days, in the Jun 30 2019 quarter.

Within Healthcare sector Avedro Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2019 compared to previous quarter at no. .

AVDR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Avedro Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVDR Inventory Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth -12.39 % 6.23 % - - -
Inventory Turnover Ratio (TTM) 2.28 3.13 4.81 7.72 -
AVDR's Total Ranking # # # # #
Average inventory processing period 160 117 76 47 -
Seq. Inventory Growth -8.94 % 10.04 % 5.02 % - -
Seq. Cost of Sales Growth -13.56 % 21.76 % -20.17 % 4.26 % 4.81 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



AVDR Company Profile >> Back to AVDR Efficiency Comparisons >> Compare AVDR Inventory Turnover Ratio to its Competitors

Financial Statements
Avedro Inc's Inventories $ 4 Millions Visit AVDR's Balance sheet
Avedro Inc's Cost of Revenues TTM $ 10 Millions Visit AVDR's Income Statement
What are AVDR's Sales? Visit AVDR's Sales by Segment

Other Inventory Turnover Ratios
Avedro Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AVDR's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AVDR's Competitors
Inventory Turnover Ratio for AVDR's Suppliers
Inventory Turnover Ratio for AVDR's Customers

You may also want to know
AVDR's Sales Growth Rates AVDR's Pe Price to earnings ratio AVDR's Receivables Turnover Ratio AVDR's Stock Quote
AVDR's Net Income Growth Rates AVDR's Ps Price to Sales ratio AVDR's Sales per Employee AVDR's Asset Turnover Ratio
AVDR's Net Margin AVDR's Pb Price to Book ratio AVDR's Financial Strength Ratios AVDR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2019 Inventories at quarter ending Sep 30 2019
Resmed Inc   6.02 $ 1,948.065  Millions$ 324  Millions
Advanced Container Technologies Inc   6.02 $ 1.027  Millions$ 0  Millions
T2 Biosystems Inc   5.99 $ 18.783  Millions$ 3  Millions
Polarityte Inc   5.96 $ 2.017  Millions$ 0  Millions
Bristol myers Squibb Company  5.85 $ 7,276.000  Millions$ 1,245  Millions
Neuronetics Inc   5.75 $ 14.881  Millions$ 3  Millions
Biocardia Inc   5.66 $ 0.437  Millions$ 0  Millions
Eagle Pharmaceuticals inc   5.59 $ 52.321  Millions$ 9  Millions
Tandem Diabetes Care Inc   5.58 $ 154.631  Millions$ 28  Millions
Cytosorbents Corporation  5.57 $ 7.352  Millions$ 1  Millions
Amag Pharmaceuticals inc   5.48 $ 151.026  Millions$ 28  Millions
Camp4 Therapeutics Corporation  5.48 $ 212.248  Millions$ 39  Millions
Patterson Companies Inc   5.46 $ 4,377.262  Millions$ 801  Millions
Henry Schein Inc   5.45 $ 7,501.916  Millions$ 1,378  Millions
Invacare Holdings Corporation  5.37 $ 677.297  Millions$ 126  Millions
West Pharmaceutical Services Inc   5.34 $ 1,206.100  Millions$ 226  Millions
Idexx Laboratories Inc  5.32 $ 1,016.452  Millions$ 191  Millions
Lantheus Holdings Inc   5.31 $ 170.171  Millions$ 32  Millions
Adm Tronics Unlimited Inc   5.31 $ 1.758  Millions$ 0  Millions
Genmark Diagnostics Inc   5.27 $ 55.445  Millions$ 11  Millions
Gilead Sciences Inc   5.25 $ 4,562.000  Millions$ 870  Millions
Sensus Healthcare Inc   5.24 $ 9.874  Millions$ 2  Millions
Hill rom Holdings Inc   5.11 $ 1,482.300  Millions$ 290  Millions
Plus Therapeutics Inc   5.01 $ 0.536  Millions$ 0  Millions
Dexcom Inc   4.94 $ 506.200  Millions$ 103  Millions
Micron Solutions Inc  4.93 $ 16.372  Millions$ 3  Millions
Endo International Plc  4.83 $ 1,602.496  Millions$ 332  Millions
Quorum Health Corporation  4.76 $ 202.419  Millions$ 43  Millions
Societal Cdmo Inc   4.76 $ 51.645  Millions$ 11  Millions
Dmk Pharmaceuticals Corporation  4.74 $ 14.324  Millions$ 3  Millions

Date modified: 2026-09-08T15:09:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.